Novel Topical JAK Inhibitor for Atopic Dermatitis Treatment
Topical JAK inhibitor achieved 58% IGA 0/1 response at week 8. Rapid itch relief within 24 hours in majority of...
Company: Pfizer
Pfizer Inc. – Global pharmaceutical company
Dupilumab Efficacy in Adolescent Atopic Dermatitis
Dupilumab achieved clear/almost clear skin in 42% of adolescents by week 16. Significant improvement in itch and quality of life.
Oral Minoxidil for Female Pattern Hair Loss
Low-dose oral minoxidil increased hair density by 18% at 24 weeks. Patient satisfaction high with minimal side effects.
AI-Assisted Melanoma Detection in Primary Care
AI algorithm sensitivity 94% for melanoma detection vs 78% for general practitioners. Specificity 89% vs 85%.
Efficacy of Drug X in Metastatic Lung Cancer: A Phase 3 Study
Phase 3 study demonstrates significant improvement in progression-free survival with Drug X in metastatic NSCLC patients.